Valacyclovir in the treatment of primoinfection due to genital herpesvirus: Comparative study;Valaciclover en el tratamiento de la primoinfección por el virus del herpes genital: Estudio comparativo

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 19, Issue 1, 2001, Pages 15-18

  García, Ángel ^a   García, Silvia ^b   Sánchez, Juan Antonio ^a   García, Ignacio ^a   Lanchares, Juan Luis ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Acyclovir; Genital herpes; Valaciclovir

Indexed keywords

ACICLOVIR; VALACICLOVIR; ANTIVIRUS AGENT; DRUG DERIVATIVE; VALINE;

ADULT; ARTICLE; BLADDER INJURY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GENITAL HERPES; HERPES VIRUS; HUMAN; MAJOR CLINICAL STUDY; PAIN; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; ADOLESCENT; COMPARATIVE STUDY; DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PARESTHESIA; PATIENT ATTITUDE; TREATMENT OUTCOME;

ACYCLOVIR; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HERPES GENITALIS; HUMANS; PAIN; PARESTHESIA; PATIENT ACCEPTANCE OF HEALTH CARE; TREATMENT OUTCOME; VALINE;

EID: 0034745360     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0213-005X(01)72542-6     Document Type: Article

References (32)

1. Quan I. Investigation on the incidencia of genital herpes in different professional groups in Qindao. Chung Hua Lius Tsa Chih 1993; 14: 262-265.
2. Mertz GJ. Herpes simplex virus En: Galasso GJ, Whitley RJ, Merigan TC, eds. New York. Raven Press, 1990; 65.
3. Patel R, Bodsworth NJ, Woolley P, Saari S, Gibb J, Robinsisn J. Valaciclovir for the supression of the recurrente genital HVS infection: A placebo controlled study of once therapy. Genitourin 1997; 73: 105-109.
4. Reeves WC, Correy L, Adams MG, Vontver R, Holmes K. Risk of recurrence after first episodes of genital herpes. Relations to VHS type and antibody response. N Engl J Med 1981; 305: 315-319.
5. Barberi Daste J, Viraben R, Icart J. Viroses et cancer de la vulva. Rev Franc Ginecol Obst 1987; 82: 583-585.
6. Costa S, Rotola J, Terzano P, Poggi MG, Di-Luca D. Search for herpes simplex virus 2 and human papillomavirus genetic expression in vulvar neoplasia J Rep Med 1990; 35: 1.108-1.112.
7. Bornstein J, Ben-Porath E, Nizari M, Satinger Y. Evaluation of monoclonal antibody-based enzyme inmunoassay for early detection of herpes simplex virus genital infection. ISR J Med Sci 1993; 29: 445-448.
8. Prober CG. Herpatic vaginitis. Clin Obst Ginecol 1993; 36: 177-178.
9. Koelle DM, Benedetti J, Langenberg A, Corey L. Asyntomatic reactivation of herpes, simplex virus in women after the first episode of genital herpes. Ann Inter Med 1992; 116: 433-437.
10. Maccato ML, Kaufman RH. Herpes genitalis. Dermatol Clin 1992; 9: 433-437.
11. Burnette TC, de Miranda P. Metabolic disposition of the aciclovir Prodrugs valaciclovir in the rat. Drug Metab Dispos 1992; 3: 157-164.
12. a ed). Buenos Aires: Panamericana, 1992.
13. Alrabiah FA, Sacks SL. New antiherpesvirus agents. Their targets and therapeutic potential. Drugs 1996; 52: 17-32.
14. Brugha R, Keersmaekers K, Renton A, Meheus A. Genital herpes infection A review. Int J Epidemiol 1997; 26: 698-709.
15. Beutner K. Valaciclovir a review of its antiviral activity pharmacokinetic properties and clinical efficacy. Ant Resear 1995; 28: 181-290.
16. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in inmunocompetent women. Effect of acyclovir treatment. J Clin Inv 1997; 99: 1.092-1.097.
17. Patel R, Cowan FM, Barton SE. Avisinng patients with genital herpes. Brit Med J 1997; 314: 85-86.
18. Barton SE, Munday PE, Patel RJ. Asyntomatic shedding of herpes simplex virus from the genital tract: Uncertainly and its consequences for patient management. The herpes simplex virus advisory Panel. Int J Std Aids 1996; 7: 229-232.
19. Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996; 124: 8-15.
20. Brocklehurst P, Roberts T. Should acyclovir prophylaxis be use in late pregnancy in women with recurrent genital herpes infection? How to use a clinical decision analisis. Obstet Gynecol 1997; 73: 314-319.
21. Randolph AG, Hartshorn RM, Washington AE. Acyclovir profilaxis in late pregnancy to prevent neonatal herpes: A const-effectiveness analysis. Obstet Gynecol 1996; 88: 603-610.
22. Tyring S, Douglas J, Corey L, Spruance S. A randomized, placebo-controlled comparison oral valaciclovir and acyclovir in inmunocompetent patients with recurrent genital herpes infections. Arch Dermatol 1998; 134: 185.
23. Posavad C, Koelle MD, Shaughnessy M, Corey L. Severe genital herpes infections in HIV infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses. Proc Natl Acad Sci 1997; 94: 10.289-10.294.
24. Perry NC, Faulds D. Valaciclovir: A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpes virus infection. Drugs 1996; 52: 754-772.
25. Fife K, Barbarash R, Rudolph T, De Gregorio B, Roth R. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an International multicenter double-blind, randomized clinical trial. The valaciclovir international herpes simplex virus stugy group. Sex Trasm Dis 1997; 24: 481-486.
26. Patel R, Bodsworth T, Woohey P, Peters B, Vejlsgaard G, Saari S. Valaciclovir for the suppresion of genital VSH infection: A placebo controlled study group. Genitourin Med 1997; 73: 105-109.
27. Perry C, Faulds D. Valaciclovir. A review of its antiviral activity pharmacokinetic properties and therapeutic efficacy in herpes virus infections. Drugs 1996; 52: 754-772.
28. Wagstaff A, Faulds D, Goa K Acyclovir, a rea praisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994; 47: 153-205.
29. Whitley R, Gnaan J. Acyclovir a decade later. N Engl J Med 1992; 327: 782-789.
30. Acosta, E, Fletcher C. Valaciclovir. Ann, Farmacol 1997; 31: 185-191.
31. Weller MS, Blum R, Doucette M, Burnette T, Cederberg D. Pharmacokinetics of the acyclovir pro-drug valaciclovir, after escalating single and multiple-dose administration to normal volunteers. Clin Pharmacol Therap 1993; 54: 595-609.
32. Beutner K. Valaciclovir: a review of its antiviral activity, pharmacokinetic properties and clinical efficacy. Antiv Researcch 1995; 28: 281-290.